ArticleFrontiers in oncology2022

Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies.

Gretchen Bergado-Báez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.